Nanobiotix
NBTX
7 hedge funds and large institutions have $28.8M invested in Nanobiotix in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
1.65% less ownership
Funds ownership: 11.75% → 10.11% (-1.6%)
22% less funds holding
Funds holding: 9 → 7 (-2)
38% less capital invested
Capital invested by funds: $46.5M → $28.8M (-$17.7M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$5.68M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$532K |
| 3 |
Millennium Management
New York
|
-$93.2K |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$88.7K |
| 5 |
Morgan Stanley
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $11.6M | – | – | – |
|
|
PA
2
Perceptive Advisors
New York
| $8.58M | – | – | – |
|
|
AG
3
Artal Group
Luxembourg
| $8.1M | – | – | – |
|
|
WP
4
Woodline Partners
San Francisco,
California
| $345K | -$88.7K | -9,063 | -18% |
|
|
5
Millennium Management
New York
| $101K | -$93.2K | -9,521 | -44% |
|
|
6
UBS Group
Zurich,
Switzerland
| $48K | -$532K | -54,340 | -90% |
|
|
AWM
7
Activest Wealth Management
Aventure,
Florida
| $2K | – | – | – |
|
|
O
8
OrbiMed
New York
| – | -$5.68M | -500,000 | Closed |
|
|
9
Morgan Stanley
New York
| – | -$3K | -300 | Closed |
|
NBTX Hedge Fund Activity: Q4 2021 in Review
7 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q4 2021, worth a combined $28.8M — down 38% from $46.5M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NBTX and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 0 added.
The largest seller was OrbiMed, exiting entirely with an estimated $5.68M sold.
- 7 institutional investors held Nanobiotix (NBTX) as of Q4 2021, down from 9 in Q3 2021.
- Funds reported $28.8M of Nanobiotix stock for Q4 2021, down 38% quarter-over-quarter.
- 0 funds opened new Nanobiotix positions in Q4 2021 and 2 closed out, a net change of -2 holders.
- The largest Nanobiotix seller in Q4 2021 was OrbiMed, an estimated $5.68M sold.
Based on aggregated 13F filings for Q4 2021.